"Northwestern Medicine is proud to have five hospitals ranked among “America’s Best” by U.S. News & World Report, 2021-22. Anchored by Northwestern Memorial Hospital, the #1 hospital in Illinois and a top 10 hospital in the nation, we’re leading the quest for better care and better treatments in the Chicagoland area. With more than 200 locations across Chicagoland, better care and better treatments are never far from home. To learn more, visit our website."

During the past decade, Northwestern Medicine Cancer Center Warrenville conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 80 clinical trials were completed, i.e. on average, 67.2% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 58 clinical trials were completed. i.e. 128.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwestern Medicine Cancer Center Warrenville" #1 sponsor was "National Cancer Institute (NCI)" with 78 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "NRG Oncology" with 20 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern Medicine Cancer Center Warrenville" #1 collaborator was "National Cancer Institute (NCI)" with 98 trials as a collaborator, "NRG Oncology" with 34 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern Medicine Cancer Center Warrenville" are "Breast Cancer" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Fallopian Tube Transitional Cell Carcinoma" (9 trials), "Ovarian Seromucinous Carcinoma" (9 trials) and "Fallopian Tube Clear Cell Adenocarcinoma" (8 trials). Many other conditions were trialed in "Northwestern Medicine Cancer Center Warrenville" in a lesser frequency.

Most popular intervention types in "Northwestern Medicine Cancer Center Warrenville" are "Drug" (148 trials), "Other" (125 trials), "Biological" (76 trials), "Procedure" (54 trials) and "Radiation" (51 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (60 trials), "Laboratory Biomarker Analysis" (59 trials), "Questionnaire Administration" (34 trials), "Paclitaxel" (31 trials) and "Computed Tomography" (27 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Medicine Cancer Center Warrenville" are 131 trials for "All" genders, 50 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Northwestern Medicine Cancer Center Warrenville". undefined are not yet recruiting, 49 are recruiting, 86 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Northwestern Medicine Cancer Center Warrenville, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Medicine Cancer Center Warrenville, 2 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 124 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".